Mice infected with encephalomyocarditis virus develop a severe state of hyporeactivity to interferon induction. One mechanism possibly responsible for development of hyporesponsiveness in these animals is a circulating factor which can be detected in their serum 96 h after encephalomyocarditis virus infection (at the time of peak hyporeactivity in vivo). This report describes some of the physicochemical characteristics of this serum hyporeactive factor (SHF). SHF is a protein with a molecular weight between 20,000 and 40,000 that was extremely labile at 56 C, losing greater than 90% of its biological activity in 8 min, but stable at 37 C for at least 4 h. Hyporeactive factor was also stable over a pH range of 2 to 11 for 48 h at 4 C. These results suggest that SHF is physicochemically similar to interferon. However, no interferon could be detected in the SHF preparation, and no loss in biological activity was observed when the serum factor was incubated with anti-interferon antibody, suggesting that they are separate substances.
Mice infected with encephalomyocarditis virus develop a severe state of hyporeactivity to interferon induction. One mechanism possibly responsible for development of hyporesponsiveness in these animals is a circulating factor which can be detected in their serum 96 h after encephalomyocarditis virus infection (at the time of peak hyporeactivity in vivo). This report describes some of the physicochemical characteristics of this serum hyporeactive factor (SHF). SHF is a protein with a molecular weight between 20,000 and 40,000 that was extremely labile at 56 C, losing greater than 90% of its biological activity in 8 min, but stable at 37 C for at least 4 h. Hyporeactive factor was also stable over a pH range of 2 to 11 for 48 h at 4 C. These results suggest that SHF is physicochemically similar to interferon. However, no interferon could be detected in the SHF preparation, and no loss in biological activity was observed when the serum factor was incubated with anti-interferon antibody, suggesting that they are separate substances.
Mice infected with encephalomyocarditis (EMC) virus progressively lose their ability to produce interferon upon exposure to any of several viral or nonviral inducers (11) . Although an explanation for the progressive decrease in interferon responsiveness of EMC virus-infected mice is not available at the present time, Stringfellow and Glasgow (12) have reported that serum taken from mice 96 to 120 h after infection with EMC virus does contain a factor(s) capable of transferring hyporeactivity to otherwise normal murine cells in vitro. These findings were particularly interesting since neither interferon nor EMC virus could be detected in the hyporeactive serum and suggested that another factor (serum hyporeactive factor [SHF] ) may be responsible for the development of hyporesponsiveness in infected animals.
Mice infected with other viruses (Friend leukemia virus [3] , cytomegalovirus [8] , and lymphocytic choriomeningitis virus [5] ) also develop a state of hyporeactivity. DeMaeyerGuignard (3) has reported that serum from Friend leukemia virus-infected mice may also contain a factor capable of mediating hyporeactivity. If a similar state of hyporesponsiveness develops in man as a consequence of infection, it may represent a major limitation to the use of interferon inducers as effective therapeutic, antiviral agents. The following studies were, therefore, undertaken to determine the physico- MATERIALS AND METHODS Mice. Female ICR strain mice (Upj:tuc-ICR) were provided by Upjohn Rearing and Procurement and were housed under conditions of constant temperature and a 12-h light cycle, with food and water provided ad libitum. After being received from the breeder, mice were housed as described for at least 1 week to allow them to adjust to the new environment before being used.
Cells. Murine interferon assays were carried out in a cloned continuous line of mouse L-cell fibroblasts (L92*) originally obtained from the American Type Culture Collection Cell Repository. Secondary mouse embryo fibroblasts (MEF) were obtained by sacrificing pregnant ICR mice near term. The embryos were removed aseptically and washed in phosphate-buffered saline (PBS), and the head and limbs were removed. The embryos were then minced, washed in PBS, and trypsinized. After centrifugation, cells were resuspended in Eagle minimum essential medium (MEM) at 5 x 104 cells/ml and distributed into sterile 32-oz (ca. 0.95-liter) prescription bottles, 100 ml/bottle. After incubation for 3 days at 37 C, confluent monolayers were obtained. These cells were removed from the glass bottles with 0.25% trypsin (1:250, Difco) and suspended at 5 x 101 cells/ml in MEM. Two milliliters of this preparation was distributed into each 35-mm plastic petri dish. Confluent monolayers were obtained in 48 h.
Media. Eagle MEM (Microbiological Associates) containing 10% fetal calf serum (Reheis Chemical Co., Phoenix, Ariz.), 100 U of penicillin per ml, and 50 Ag of streptomycin per ml was used to propagate and maintain all tissue cultures.
Viruses. The Herts strain of Newcastle disease virus (NDV) was originally obtained from S. Baron (National Institutes of Health [NIH] ). The stock NDV preparation used in these experiments was propagated in embryonated hen eggs which had been injected by the allantoic route and had a titer of 2.0 x 109 plaque-forming units (PFU)/ml in primary chicken embryo cells.
Vesicular stomatitis virus (VSV), Indiana strain, was obtained from the American Type Culture Collection (Rockville, Md.). Pools of VSV were propagated in primary chicken embryo cell monolayers. The stock preparation of VSV used in these studies had a titer of 2 x 107 PFU/ml when assayed in L,2, mouse cells.
The strain of EMC virus used in these studies was a large plaque variant originally obtained from K. K. Takemoto (NIH). Suckling mice were injected by the intracerebral route, and brains were removed at the height of disease. These tissues were homogenized, and a 10% suspension in MEM was used as a stock pool with a titer of 2.5 x 106 PFU/ml in L,9, mouse cells.
Interferon assay. Confluent monolayers of L,29 cells grown in 35-mm plastic petri dishes (Falcon Plastics) were treated with 1 ml of an appropriate interferon dilution overnight at 37 C. The plaque reduction assay used VSV as the challenge virus and has been previously described (11) . An internal laboratory reference murine interferon standard was included with each interferon assay, and the sensitivity of our assay was compared with the Intemational Murine Standard obtained from the NIH. In our system, the International Standard had a mean titer of approximately 4,200 U/ml compared with its accepted titer of 6,500 U/ml.
Preparation of serum from EMC virus-infected mice. Female ICR strain mice (20 g) were infected intraperitoneally with a 100% lethal inoculum (1,000 PFU) of EMC virus. One hundred hours after infection, mice were bled by cardiac puncture. The blood was allowed to clot at room temperature for 1 Hyporeactivity assay. Serum to be assayed for its ability to transfer hyporeactivity to normal cells was diluted serially in MEM. Growth medium was removed from confluent 20 MEF monolayers grown in 35-mm plastic petri dishes (Falcon Plastics), and plates (in triplicate) received 1 ml of the appropriate dilution of serum from EMC virus-infected mice, normal mouse serum, or MEM. Cell cultures were returned to 37 C for 24 h, at which time each plate received 0.1 ml of NDV (4 x 107 PFU) or MEM. Growth medium was harvested from cells 24 h after inducer challenge and frozen at -20 C until assayed for interferon. All samples were held at a pH of 2.0 for 5 days at 4 C before being assayed for interferon.
RESULTS
The following studies were undertaken to determine the physical-chemical nature of the hyporeactive factor in serum from EMC virusinfected mice (SHF). In each case the hyporeactive assay and interferon assays were run as described in Materials and Methods. A single pool of serum from normal or EMC virusinfected mice was used throughout these studies.
Heat stability of SHF. The stability of SHF was determined at 56 and 37 C. Serum from EMC virus-infected or normal uninfected mice was diluted 1:5 in MEM and divided into 0.75-ml portions. At 0 time all tubes were immersed in a 56 or 37 C water bath. At specified times tubes were removed and immediately frozen in a dry ice-acetone bath. All samples were stored frozen at -20 C until assayed for their ability to reduce the interferon response of 20 MEF cells to NDV. The results illustrated in Fig. 1 indicate that at 56 C SHF was extremely labile. By 8 min, greater than 90% of the biological activity of SHF was lost. For example, cells treated with a 1:30 dilution of unheated serum from infected mice produced only 270 U of interferon per ml of growth media, whereas cells treated with the same dilution of serum heated at 56 C for 8 min produced 1,700 U of interferon per ml. No appreciable difference was seen between SHF heated at 56 C for 8 min or longer or normal mouse serum. Apparently almost all activity was destroyed within the first 8 min. The interferon response of cells treated with each dilution of serum heated at 56 C for 4 min consistently produced more interferon than did cells treated with comparable dilutions of unheated serum, indicating that some biological activity was lost within 4 min. Fig. 3 demonstrate that no loss of biological activity resulted due to dialysis, and, therefore, SHF was assumed to have a molecular weight greater than 10,000.
Centrifugation of SHF at 10,000 x g for 2 h. The previous study indicated that the hyporeactive factor present in serum from EMC virus-infected mice had a molecular weight greater than 10,000. To further estimate its molecular weight and to determine if the factor was incomplete or noninfectious virus, samples of serum from normal uninfected and EMC virus-infected mice were diluted 1:5 in MEM and centrifuged at 40,000 rpm for 2 h at 4 C in a model L Spinco ultracentrifuge using a number 40 rotor. After centrifugation, the top two-thirds of supernatant fluid was removed from each tube and assayed for hyporeactivity on 20 MEF cells using NDV as the inducer. In this assay a presented in Fig. 5 indicate that the hyporeactive factor was stable for at least 48 h at a pH as low as 2 or as high as 11. Using a linear regression analysis of variance to determine the line of best fit, no significant difference was seen between the amount of interferon induced in the cells treated with each dilution of pH-treated or untreated SHF. Normal mouse serum did not significantly impair the ability of the MEF cells to produce interferon and, although not shown, pH treatment of normal mouse serum did not affect the amount of interferon induced in cells treated with these preparations.
Trypsin and RNase sensitivity of SHF. To further determine the chemical nature of SHF, serum from normal or EMC virus-infected mice was diluted 1:5 in Hanks balanced salt solution and 50 ,ug of trypsin per ml (3x crystallized; Worthington Biochemical Corp., Freehold, N.J.), 50 ug of ribonuclease A (RNase) per ml (Worthington Biochemical), or 0.2 ml of PBS was added to each tube. The mixtures were incubated in a 37 C water bath for 1 h. As controls, a solution of poly(I:C) (100,ug/ml; PL (Fig. 4) (Fig. 6, 7) . Cells treated with a 1:10 dilution of serum from EMC virus-infected mice that had been incubated with PBS produced only 10 U of interferon per ml of growth medium in response to NDV, but cells treated with the same dilution of serum that had been trypsin treated produced 400 U of interferon per ml (Fig. 6) . The amount of interferon induced by NDV in 20 MEF cells was, on the other hand, approximately the same in cells treated with each dilution of serum from infected mice that had been incubated with RNase or PBS (Fig. 7) . Neither RNase nor trypsin treatment altered the effect of normal mouse serum on the interferon response of cells. Although not shown, trypsinization destroyed greater than 95% of the biological activity of the interferon preparation but had no effect upon the ability of poly(I:C) to create an antiviral state in rabbit kidney cells. RNase treatment, as expected, had the opposite effect: complete destruction of any detectable biological activity of poly(I:C) and no effect on the interferon control. These results indicate that trypsin selectively destroyed the biological activity of protein or polypeptides while not affecting ribonucleic acid integrity, and RNase destroyed ribonucleic acid activity without affecting the biological activity of proteins.
G-200 chromatography of serum from EMC virus-infected mice. Using Sephadex chromatography, the molecular weight of the hyporeactive factor in serum from EMC virus-infected mice was determined. Fractionation of serum utilized a 60-by 1.6-cm column (Pharmacia) with a 48-by 1.6-cm bed volume of Sephadex G-200 superfine (Pharmacia), using 0.1 M tris-(hydroxymethyl)aminomethane-hydrochloride buffer at pH 8.0 with 0.2 M NaCl and 0.02% sodium azide. After the addition of 2 ml of serum from EMC virus-infected mice, 0.85-ml fractions were collected and the absorbance of each fraction was read using a Cary model 11 UV spectrophotometer (Applied Physics Corp.) at 280 uM. Fractions were then pooled into 12 equal pools. These samples were dialyzed for 24 h against PBS at 4 C and were then frozen at -20 C until assayed for hyporeactivity on 20 MEF cells using NDV as the inducer. The only pool that demonstrated any hyporeactivity was that comprised of fractions 61-69 (Fig. 8 ). Cells treated with dilutions of this pool ranging from 1:2 to 1:32 produced less than 50% of the interferon response of cells treated with MEM or comparable dilutions of normal mouse serum (1:2 = 230 U/ml; 1:32 = 950 U/ml; MEM control = 2,200 U/ml; normal mouse serum 1:2 control = 1,500 U/ml). Higher dilutions of this pool had no significant effect on the amount of interferon induced by NDV.
The molecular weight of the hyporeactive factor was determined using a calibration curve, established by chromatography of several proteins of known molecular weight. After the serum, described above, had passed through the column, the column was rinsed with approximately 100 ml of tris(hydroxymethyl)aminomethane-hydrochloride buffer, and then 2 ml of a solution containing purified horse gamma globulin (Upjohn), tryptophan (Schwarz/Mann), bovine serum albumin (Schwarz/Mann), and cytochrome c (Schwarz/Mann) (5 mg/ml of each) was chromatographed. The elution volume of each of these proteins was determined, and, using the formula Kav = Ve -V/V, -Vo where Ve is the elution volume, V, is the total bed volume, and V0 is the void volume, the Kav of each was plotted against the log10 of their molecular weight (Fig. 9) . Using a linear regression analysis of variance, the line of best fit was determined, and the molecular weight of the hyporeactive factor was estimated to be between 20,000 and 40,000 using the Kav of fractions 61 and 69.
To check the validity of these calculations, the molecular weight of the third major peak in Fig. 8 (Table 1) . Tubes \ ALBUMIN were shaken and held at 37 C for 0.5 h. SHF-* antibody mixtures were then assayed for hypo-
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RNase. Heating at 56 C for as little as 8 min determine if the hyporeactive factor in destroyed greater than 90% of the biological from EMC virus-infected mice was an activity of SHF. At 37 C, however, SHF was I form of interferon that lacked antiviral stable, with no detectable loss in hyporeactivity y, the effect of anti-interferon antibody during a 4-h period. The hyporeactive protein in biological activity of SHF was investi-serum from infected mice was stable over a pH Rabbit anti-interferon globulin was ob-range of 2 to 11 for 48 h at 4 C and had, by through the Antiviral Substances Pro-fractionation on Sephadex G-200, an estimated of the NIH. Partially purified, NDV-molecular weight of from 20,000 to 40,000.
d, L-cell interferon had been used as the These conclusions are supported by the obseriogen, and sera had been inactivated at vation that SHF was non-dialyzable and was )r 30 min. The globulin fraction had been not sedimented when centrifuged at 100,000 x g itated and purified by sequential absorp-for 2 h. Serum from EMC virus-infected mice i.e., calf serum and L-cell extracts) to has previously been reported to be species a Equal volumes of each dilution of serum from EMC-infected mice (SHF), interferon (induced by EMC (virus), or MEM were added to each dilution of anti-interferon globulin or MEM and incubated at 37 C for 30 min. These mixtures were then assayed for hyporeactivity on 20 MEF cells using NDV as the inducer, or for interferon using a VSV plaque reduction assay.
b Interferon levels (units/milliliter) induced by MEF cells treated with SHF-ab mixtures. c Average number of VSV plaques per L929 plate (three plates per dilution) treated with interferon-ab mixtures. specific in the sense that it rendered three types of murine cells hyporeactive to interferon induction by NDV, but had essentially no effect on the interferon responsiveness of heterologous cells, including rabbit, chicken, and human cells (12) . Also, SHF had no effect on the sensitivity of murine cells to the antiviral action of interferon (12) . Although these results suggest similarities between SHF and interferon, no neutralization of the biological activity of SHF was observed when incubated with anti-interferon globulin that could neutralize the antiviral activity of EMC virus-induced interferon.
When cells are challenged with interferon inducers they often become refractory to new stimulation. Also, cells exposed to interferon prior to induction can exhibit either an enhanced (primed) or reduced (hyporeactive) interferon response (2, 4, 6, 7, 9, 13, 15 Abstr. 196, 1973) have suggested that an inhibitor with the same physicochemical properties as interferon was produced coincidentally with interferon, and that interferon preparations harvested early after inducer contained little or no hyporeactive factor whereas interferon harvested later contained high levels of hyporeactive factor. Furthermore, there was no apparent relationship between the amount of interferon or hyporeactive factor in any of their preparations. Using various purification techniques, however, they were unsuccessful in separating the postulated hyporeactive factor from interferon. Rousset (10) likewise found that interferon or an interferon-like material was apparently responsible for hyporeactivity. Vilcek et al. (14) , however, have reported that the addition of actinomycin D a short time after induction potentiated the interferon response of rabbit kidney cells, suggesting that another protein whose synthesis is induced by high levels of interferon was responsible for cellular control of interferon production (hyporeactivity). 301 VOL. 11, 1975 on November 1, 2017 by guest http://iai.asm.org/
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Although our experiments used an entirely different system than any previously reported, and production of the hyporeactive factors was an in vivo process using an active virus infection of mice, the possibility exists that the SHF characterized in this paper and that reported previously (Borden et Abstr. 196, 1973) in other systems may be the same. Using various physical and chemical criteria, the only difference between SHF and murine interferon was that hyporeactive factor was not neutralized by anti-interferon globulin whereas EMC virus-induced interferon was, suggesting that they are similar but unrelated molecules. It should be further emphasized that no interferon activity, as measured by using a plaque reduction assay system, could be detected in the serum from EMC virus-infected mice used in these studies. Cells treated with a 1:20 dilution of serum from EMC virus-infected mice developed no antiviral activity, yet produced less than 5% of the interferon levels induced by NDV in MEM-or normal mouse serum-treated cells. Using an in vivo system, an interferon-free preparation of SHF was obtained by waiting until the animal had cleared the interferonemia before serum was drawn. Other systems which have employed in vitro production of hyporeactive factor have in every case had interferon in the preparation, and differentiation of the action of hyporeactive factor and interferon has not been possible due to the apparent close similarity of the two molecules (Borden et Although the serum hyporeactive factor described in this report may not be the same hyporeactive factor whose existence has previously been postulated, the possibility is intriguing. Whether the factor present in the serum of EMC virus-infected mice is a virus-specific substance designed to inhibit the interferon component of host defense or is a specific (natural) cellular or physiological mechanism responsible for control of interferon production is at the present time unknown. Studies are under way to purify, further characterize, and determine the mechanism of action of SHF. Such information would seem essential to understanding how or why animals develop hyporeactivity to interferon induction and could in turn be beneficial in developing methods of overcoming a potentially severe limitation to the use of interferon inducers as effective therapeutic antiviral agents, as well as further defining conditions that may influence the virulence of specific virus infections.
